SPONSOR
Peking University Third Hospital
Total Trials
13
Recruiting
13
Phases
Phase 4
Conditions studied: IVF OutcomeOvarian NeoplasmsAtrial FibrillationAsthma ExacerbationsDiabetic WoundWound InfectionWound HealPCOSObesityInfertility
Peking University Third Hospital is a clinical research sponsor with 13 registered studies on ClinicalTrials.gov, of which 13 are actively recruiting participants. Research covers conditions including IVF Outcome, Ovarian Neoplasms, Atrial Fibrillation, Asthma Exacerbations.
The trial portfolio spans Phase 4 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — Peking University Third Hospital
How many clinical trials has Peking University Third Hospital sponsored?
ClinicalMetric currently tracks 13 clinical trials sponsored by Peking University Third Hospital, of which 13 are actively recruiting participants. These trials cover conditions including IVF Outcome, Ovarian Neoplasms, Atrial Fibrillation. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Peking University Third Hospital research focus on?
Peking University Third Hospital clinical trials span IVF Outcome, Ovarian Neoplasms, Atrial Fibrillation, Asthma Exacerbations, Diabetic Wound, and additional conditions. The research pipeline includes Phase 4 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a Peking University Third Hospital clinical trial?
To participate in a Peking University Third Hospital trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Peking University Third Hospital trials with current recruitment status updated daily.
Clinical Trials by Peking University Third Hospital
NCT04163133
Recruiting
Trigger Timing in Ovarian Stimulations
IVF Outcome
NCT06564428
Recruiting
A Cohort Study of Hereditary Ovarian Cancer Risk Prediction Models and Pathogenesis Exploration
Ovarian Neoplasms
NCT05638841
Recruiting
Prospective Cohort Study of the Risk of Recurrent Atrial Fibrillation After Radiofrequency Ablation
Atrial Fibrillation
NCT06621056
Recruiting
A Cohort Study of Risk Factors and Prognosis for Frequent Acute Asthma Exacerbations Phenotype
Asthma Exacerbations
NCT06841237
Recruiting
Randomized Controlled Trial on the Efficacy and Safety of Xiang Lei Ointment in Diabetic-related Ulcer Management
Diabetic Wound
NCT06742710 Phase 4
Recruiting
Liraglutide Treatment in Obese Infertile PCOS Women
PCOS
NCT07306221
Recruiting
Effect of Visual-Guided Balance Training on Knee Motor Function and Biomechanical Characteristics After ACL Reconstruction
Anterior Cruciate Ligament Injuries
NCT06341062
Recruiting
The Application of Contrast-enhanced Ultrasound in Acute Kidney Injury in ICU
Intensive Care Unit
NCT05605314
Recruiting
Clinical Cohort Study in Patients With Different Subtypes of Primary Sjogren Syndrome Related Dry Eye
Dry Eye
NCT05189054
Recruiting
Safety and Efficacy of SBRT in the Reirradiation for Ultra-central Thoracic Malignant Tumors
Stereotactic Body Radiation Therapy
NCT05973097
Recruiting
Treatment of Oral Lichen Planus With Paeoniflorin and Photodynamic Therapy
Oral Lichen Planus
NCT05349552
Recruiting
Safety and Efficacy of SBRT in the Treatment of Thoracic Malignant Tumors at Different Sites
Radiotherapy
NCT06426355
Recruiting
The Effeciency of NMN in Improving IVF/ICSI-ET Pregnancy Outcomes in Patients With DOR
Diminished Ovarian Reserve
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: September 2026 · Data Methodology